Entry
Name
Nedometinib (USAN/INN)
Formula
C17H16FIN4O3
Exact mass
470.0251
Mol weight
470.24
Structure
Mol file KCF file DB search
Class
Antineoplastic
DG03137 MEK inhibitor
Efficacy
Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor
Comment
Treatment of cutaneous neurofibromas (cNF) in patients with neurofibromatosis type 1(NF1)
Target
Pathway
Brite
Drug groups [BR:br08330 ]
Antineoplastic
DG03137 MEK inhibitor
D13039 Nedometinib
Target-based classification of drugs [BR:br08310 ]
Protein kinases
Serine/threonine kinases
STE group
MAP2K (MEK)
D13039 Nedometinib (USAN/INN)
BRITE hierarchy
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 26
1 C8y C 21.3500 -18.3400
2 C8y C 21.3500 -19.8100
3 N1b N 20.2300 -17.6400
4 C5a C 20.2300 -20.4400
5 N1b N 19.0400 -19.8100
6 O5a O 20.2300 -21.8400
7 O2a O 17.8500 -20.3700
8 C1b C 16.6600 -19.8100
9 C1b C 15.4700 -20.3700
10 O1a O 14.2800 -19.8100
11 C8y C 20.2300 -16.2400
12 C8x C 21.4200 -15.5400
13 C8x C 21.4200 -14.1400
14 C8y C 20.2300 -13.4400
15 C8x C 19.0400 -14.1400
16 C8y C 19.0400 -15.5400
17 X I 20.2300 -12.0400
18 X F 17.7800 -16.3100
19 C8y C 22.6800 -20.2300
20 C8y C 23.5200 -19.1100
21 N4y N 22.6800 -17.9900
22 N5x N 24.9200 -19.2500
23 C8x C 25.4800 -20.5800
24 C8x C 24.6400 -21.7000
25 C8x C 23.2400 -21.4900
26 C1a C 23.1700 -16.6600
BOND 28
1 1 2 2
2 1 3 1
3 2 4 1
4 4 5 1
5 4 6 2
6 5 7 1
7 7 8 1
8 8 9 1
9 9 10 1
10 3 11 1
11 11 12 2
12 12 13 1
13 13 14 2
14 14 15 1
15 15 16 2
16 11 16 1
17 14 17 1
18 16 18 1
19 2 19 1
20 19 20 1
21 20 21 1
22 1 21 1
23 20 22 2
24 22 23 1
25 23 24 2
26 24 25 1
27 19 25 2
28 21 26 1